Ensign Peak Advisors, Inc Ptc Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

$51.2 Billion
Q1 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 274,267 shares of PTCT stock, worth $17.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

274,267

Previous 208,302 31.67%

Holding current value

$17.3 Million

Previous $9.4 Million 48.65%

% of portfolio

0.03%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$41.81 - $57.17 $2.76 Million - $3.77 Million	65,965 Added 31.67%	274,267 $14 Million
Q2 2024 Aug 13, 2024	BUY	$24.69 - $40.12 $4.46 Million - $7.24 Million	180,561 Added 650.88%	208,302 $6.37 Million
Q1 2024 May 14, 2024	SELL	$24.15 - $31.95 $33,785 - $44,698	-1,399 Reduced 4.8%	27,741 $806,000
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $6 Million - $7.68 Million	-157,110 Reduced 84.35%	29,140 $1.41 Million
Q4 2022 Feb 13, 2023	BUY	$33.53 - $54.79 $5.67 Million - $9.26 Million	169,010 Added 980.34%	186,250 $7.11 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $60,682 - $78,082	1,450 Added 9.18%	17,240 $865,000
Q2 2022 Aug 12, 2022	BUY	$25.6 - $45.23 $109,312 - $193,132	4,270 Added 37.07%	15,790 $633,000
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $50,661 - $67,792	1,520 Added 15.2%	11,520 $430,000
Q4 2021 Feb 11, 2022	BUY	$35.36 - $41.86 $122,840 - $145,421	3,474 Added 53.23%	10,000 $398,000
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $445,674 - $538,759	-12,042 Reduced 64.85%	6,526 $243,000
Q1 2021 May 12, 2021	SELL	$46.8 - $68.92 $1.72 Million - $2.53 Million	-36,757 Reduced 66.44%	18,568 $879,000
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $1.26 Million - $1.77 Million	26,175 Added 89.79%	55,325 $3.38 Million
Q3 2020 Nov 12, 2020	BUY	$45.41 - $57.07 $1.03 Million - $1.29 Million	22,576 Added 343.41%	29,150 $1.36 Million
Q1 2020 May 11, 2020	SELL	$32.37 - $59.36 $330,950 - $606,896	-10,224 Reduced 60.86%	6,574 $293,000
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $541,231 - $841,075	16,798 New	16,798 $806,000

Others Institutions Holding PTCT

# of Institutions

308

Shares Held

80.1M

Call Options Held

255K

Put Options Held

151K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $4.51B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Ptc Therapeutics, Inc. Transaction History